Further supporting the involvement of fibrinolytic dysfunction in PD, Lin et al. (2022) reported that treatment with α-syn PFFs in SH-SY5Y cells resulted in the decreased expression of tetranectin (TN) and increased expression of PAI-1, leading to reduced plasmin activity. This evidence concerns the gene CLEC3B and Parkinson disease.